Novo Nordisk Boss on Ozempic and Eating Disorder Criticism, Social Media Pressure

#Ozempic #Wegovy #obesity #diabetes #weightloss #healthcare #pharmaceuticals #novonordisk #drugs #leadership #CEO

Novo Nordisk has revolutionized the weight loss market with its blockbuster diabetes and obesity drugs, Ozempic and Wegovy. Celebrities have helped their popularity soar. Elon Musk, Sharon Osborne and Chelsea Handler have all publicly talked about taking Ozempic or Wegovy and they’ve had further backing from Oprah Winfrey. It’s a global phenomenon – reaching millions on platforms like TikTok. Speaking on Bloomberg’s Leaders With Lacqua, Novo Nordisk CEO Lars Fruergaard Jørgensen discusses the challenges the company has faced on social media and why he thinks trust needs to be placed in the doctors prescribing their drugs.

Watch the full interview:

#bloomberg #leaderswithlacqua #francinelacqua
More on Bloomberg Television and Markets

Like this video? Subscribe and turn on notifications so you don’t miss any videos from Bloomberg Markets & Finance:
Visit for business news & analysis, up-to-the-minute market data, features, profiles and more.

Connect with Bloomberg Television on:

Connect with Bloomberg Business on:

More from Bloomberg:
Bloomberg Radio:

Bloomberg Surveillance:
Bloomberg Politics:
Bloomberg Originals:

Watch more on YouTube:
Bloomberg Technology:
Bloomberg Originals:
Bloomberg Quicktake:
Bloomberg Espanol:
Bloomberg Podcasts: